SAMSUNG PHARM. Co., LTD. (KRX: 001360)

SAMSUNG PHARM. Co., LTD. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep 30, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Cash & Equivalents	2,057	3,151	2,932	5,390	19,592	3,117
Short-Term Investments	1,200	1,200	1,200	2,966	13,006	-
Trading Asset Securities	7,965	29,064	22,525	4,053	6,884	-
Cash & Short-Term Investments	11,223	33,415	26,657	12,409	39,482	3,117
Cash Growth	-73.04%	25.35%	114.81%	-68.57%	1166.86%	-62.33%
Accounts Receivable	15,862	16,700	15,433	15,540	14,083	13,463
Other Receivables	3,294	3,708	3,489	689.11	640.74	676.15
Receivables	27,773	32,712	23,077	19,045	14,724	14,139
Inventory	12,022	9,309	10,582	13,161	9,678	6,144
Prepaid Expenses	104.72	24.47	52.41	727.71	963.66	24.41
Other Current Assets	1,212	1,192	609.65	2,369	649.33	2,490
Total Current Assets	52,334	76,652	60,978	47,711	65,497	25,914
Property, Plant & Equipment	78,136	73,435	75,038	72,405	42,434	30,516
Long-Term Investments	22,269	955.16	491.56	-	-	512.87
Goodwill	-	-	-	1,437	2,712	-
Other Intangible Assets	355.37	383.23	213.99	1,044	5,708	256.41
Long-Term Deferred Charges	3,414	2,846	1,956	1,701	640.71	-
Other Long-Term Assets	2,142	6,375	15,516	13,985	13,226	210.95
Total Assets	158,651	160,647	154,194	138,285	130,218	57,410
Accounts Payable	6,082	4,692	6,211	4,285	2,721	4,661
Accrued Expenses	9.93	27.47	388.64	110.69	80.93	63.47
Short-Term Debt	10,520	13,563	39,503	18,700	20,200	18,200
Current Portion of Long-Term Debt	2,161	2,748	957.96	9,176	233.77	4,442
Current Income Taxes Payable	-	2.59	-	-	-	-
Current Unearned Revenue	-	-	-	7.11	-	-
Other Current Liabilities	3,078	3,660	5,118	4,229	2,589	1,103
Total Current Liabilities	22,032	24,693	52,178	36,508	25,825	28,470
Long-Term Debt	1,422	2,150	4,906	16,307	54,231	3,395
Long-Term Deferred Tax Liabilities	-	-	-	67.31	1,298	-
Other Long-Term Liabilities	385.35	615.45	784.58	659.3	472.94	467.94
Total Liabilities	24,644	28,984	60,326	55,907	83,981	34,115
Common Stock	29,306	29,118	20,713	19,857	13,792	11,431
Additional Paid-In Capital	83,078	82,305	99,155	94,371	42,421	22,473
Retained Earnings	-4,306	-3,380	-49,655	-43,435	-21,703	-23,748
Treasury Stock	-154.04	-154.04	-154.04	-154.04	-154.04	-154.04
Comprensive Income & Other	26,084	23,774	23,809	11,739	11,881	13,293
Total Common Equity	134,007	131,663	93,868	82,378	46,237	23,295
Minority Interest	-	-	-	0	0	-
Shareholders' Equity	134,007	131,663	93,868	82,378	46,237	23,295
Total Liabilities & Equity	158,651	160,647	154,194	138,285	130,218	57,410
Total Debt	14,284	18,460	45,367	44,184	74,665	26,037
Net Cash (Debt)	-3,061	14,955	-18,710	-31,774	-35,183	-22,920
Net Cash Per Share	-52.38	291.86	-468.99	-970.09	-1379.87	-1258.54
Filing Date Shares Outstanding	58.57	58.19	41.39	39.67	27.54	22.82
Total Common Shares Outstanding	58.57	58.19	41.39	39.67	27.54	22.82
Working Capital	30,302	51,959	8,800	11,204	39,672	-2,555
Book Value Per Share	2288.01	2262.51	2268.17	2076.48	1678.78	1020.83
Tangible Book Value	133,652	131,280	93,655	79,896	37,816	23,038
Tangible Book Value Per Share	2281.94	2255.93	2263.00	2013.93	1373.05	1009.59
Land	29,533	29,533	29,533	17,446	17,446	15,177
Buildings	30,337	30,336	19,328	36,855	24,863	20,188
Machinery	21,824	19,962	8,814	15,775	19,735	20,099
Construction In Progress	23,351	18,005	17,364	19,814	2,725	265

Source: S&P Capital IQ. Standard template. Financial Sources.